FDA Clearance Tracker · P920014-S031
HEARTMATE XVE LVAS
Last checked: Nov 20, 2026Latest source record: Dec 21, 2011 (this decision)Source: openFDAMethods & limitations
Decided
Dec 21, 2011
Approved
Time to decision
359 days
Received Dec 27, 2010. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P920014-S031
- Device name
- HEARTMATE XVE LVAS
- Applicant
- Thoratec Corp
- Applicant location
- Pleasanton, CA
- Received
- Dec 27, 2010
- Decided
- Dec 21, 2011
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P920014
Device type
- Device type
- Ventricular (assist) bypass (DSQ)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A MANUFACTURING SITE LOCATED AT THORATEC CORPORATION IN SAN RAMON, CALIFORNIA FOR RECEIVING ACCEPTANCE ACTIVITIES, RECEIVING INSPECTION, WAREHOUSING, AND SHIPPING OPERATIONS.
Source documents
Other decisions for Thoratec Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.